To explore the regulatory mechanism of increased NAT10 expression in ccRCC, the PROMO website (http://alggen.lsi.upc.es/cgi-bin/promo_v3/promo/promoinit.cgi?dirDB=TF_8.3) was used to predict the transcription factors that could bind to the NAT10 promoter. The gene discussed is NAT10; the disease is nonpapillary renal cell carcinoma.